8,9-Epoxyeicosatrienoic acid inhibits antibody production of B lymphocytes in mice

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Gao, Yanxiang ^a   Feng, Juan ^a   Ma, Kongyang ^a   Zhou, Zhou ^a   Zhu, Yi ^a   Xu, Qingbo ^b   Wang, Xian ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8,9 EPOXYICOSATRIENOIC ACID; EPOXYICOSATRIENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; C57BL 6 MOUSE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GERMINAL CENTER; HUMORAL IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MITOSIS INHIBITION; MOUSE; NONHUMAN; PLASMA CELL; PROTEIN TRANSPORT; WESTERN BLOTTING;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; ANTIBODY FORMATION; APOLIPOPROTEINS E; B-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B;

MUS;

EID: 84863622557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040258     Document Type: Article

References (41)

1. LeBien TW, Tedder TF, (2008) B lymphocytes: how they develop and function. Blood 112: 1570-1580.
2. McHeyzer-Williams LJ, McHeyzer-Williams MG, (2005) Antigen-specific memory B cell development. Annu Rev Immunol 23: 487-513.
3. Kawai T, Akira S, (2005) Pathogen recognition with Toll-like receptors. Curr Opin Immunol 17: 338-344.
4. Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ, (2004) CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 22: 307-328.
5. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, et al. (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17: 51-62.
6. Shaffer AL, Shapiro-Shelef M, Iwakoshi NN, Lee AH, Qian SB, et al. (2004) XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21: 81-93.
7. Manis JP, Tian M, Alt FW, (2002) Mechanism and control of class-switch recombination. Trends Immunol 23: 31-39.
8. Oliw EH, (1994) Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases. Prog Lipid Res 33: 329-354.
9. Campbell WB, Gebremedhin D, Pratt PF, Harder DR, (1996) Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423.
10. Medhora M, Daniels J, Mundey K, Fisslthaler B, Busse R, et al. (2003) Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. Am J Physiol Heart Circ Physiol 284: H215-H224.
11. Sun J, Sui X, Bradbury JA, Zeldin DC, Conte MS, et al. (2002) Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res 90: 1020-1027.
12. Node K, Ruan XL, Dai J, Yang SX, Graham L, et al. (2001) Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem 276: 15983-15989.
13. Junier MP, Dray F, Blair I, Capdevila J, Dishman E, et al. (1990) Epoxygenase products of arachidonic acid are endogenous constituents of the hypothalamus involved in D2 receptor-mediated, dopamine-induced release of somatostatin. Endocrinology 126: 1534-1540.
14. Benoit C, Renaudon B, Salvail D, Rousseau E, (2001) EETs relax airway smooth muscle via an EpDHF effect: BK(Ca) channel activation and hyperpolarization. Am J Physiol Lung Cell Mol Physiol 280: L965-L973.
15. Node K, Huo Y, Ruan X, Yang B, Spiecker M, et al. (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285: 1276-1279.
16. Ulu A, Davis BB, Tsai HJ, Kim IH, Morisseau C, et al. (2008) Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model. J Cardiovasc Pharmacol 52: 314-323.
17. Zhang LN, Vincelette J, Cheng Y, Mehra U, Chen D, et al. (2009) Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia. Arterioscler Thromb Vasc Biol 29: 1265-1270.
18. Calder PC, (2008) The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids 79: 101-108.
19. Fedyk ER, Phipps RP, (1996) Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci USA 93: 10978-10983.
20. Okunishi K, Dohi M, Nakagome K, Tanaka R, Yamamoto K, (2004) A novel role of cysteinyl leukotrienes to promote dendritic cell activation in the antigen-induced immune responses in the lung. J Immunol 173: 6393-6402.
21. Nataraj C, Thomas DW, Tilley SL, Nguyen MT, Mannon R, et al. (2001) Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest 108: 1229-1235.
22. Harizi H, Juzan M, Pitard V, Moreau JF, Gualde N, (2002) Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 168: 2255-2263.
23. Enayetallah AE, French RA, Thibodeau MS, Grant DF, (2004) Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem 52: 447-454.
24. Liu X, Zhu P, Freedman BD, (2006) Multiple eicosanoid-activated nonselective cation channels regulate B-lymphocyte adhesion to integrin ligands. Am J Physiol Cell Physiol 290: C873-C882.
25. Zhu P, Liu X, Labelle EF, Freedman BD, (2005) Mechanisms of hypotonicity-induced calcium signaling and integrin activation by arachidonic acid-derived inflammatory mediators in B cells. J Immunol 175: 4981-4989.
26. Stavnezer J, (1996) Antibody class switching. Adv Immunol 61: 79-146.
27. Kinoshita K, Honjo T, (2000) Unique and unprecedented recombination mechanisms in class switching. Curr Opin Immunol 12: 195-198.
28. Gugasyan R, Grumont R, Grossmann M, Nakamura Y, Pohl T, et al. (2000) Rel/NF-kappaB transcription factors: key mediators of B-cell activation. Immunol Rev 176: 134-140.
29. Spector AA, (2009) Arachidonic acid cytochrome P450 epoxygenase pathway. J Lipid Res 50.
30. Campbell WB, Falck JR, (2007) Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors. Hypertension 49: 590-596.
31. Schmelzer KR, Kubala L, Newman JW, Kim IH, Eiserich JP, et al. (2005) Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci U S A 102: 9772-9777.
32. Smith KR, Pinkerton KE, Watanabe T, Pedersen TL, Ma SJ, et al. (2005) Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc Natl Acad Sci U S A 102: 2186-2191.
33. Seubert JM, Zeldin DC, Nithipatikom K, Gross GJ, (2007) Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury. Prostaglandins Other Lipid Mediat 82: 50-59.
34. Imig JD, Navar LG, Roman RJ, Reddy KK, Falck JR, (1996) Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 7: 2364-2370.
35. Cheng MK, Doumad AB, Jiang H, Falck JR, McGiff JC, et al. (2004) Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors. Br J Pharmacol 141: 441-448.
36. Katoh T, Takahashi K, Capdevila J, Karara A, Falck JR, et al. (1991) Glomerular stereospecific synthesis and hemodynamic actions of 8,9-epoxyeicosatrienoic acid in rat kidney. Am J Physiol 261: F578-F586.
37. Michaelis UR, Falck JR, Schmidt R, Busse R, Fleming I, (2005) Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells. Arterioscler Thromb Vasc Biol 25: 321-326.
38. Wray J, Bishop-Bailey D, (2008) Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology. Exp Physiol 93: 148-154.
39. Potente M, Fisslthaler B, Busse R, Fleming I, (2003) 11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1. J Biol Chem 278: 29619-29625.
40. June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB, (1987) T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol 7: 4472-4481.
41. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, et al. (1991) Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173: 721-730.